The Core Outcome Measures in Effectiveness Trial initiative aims at developing core outcome set (COS) for research.
The lack of core outcome sets for atopic eczema (AE) is a major obstacle for advancing evidence-based treatment.
Methods to develop core outcome sets, the minimum outcomes that should be measured in research in a topic area, vary.
These stakeholder-prioritized outcomes will inform the core outcome set to improve the consistency and relevance of trials in kidney transplantation.
So we thought it would be interesting to examine specifically how having women political representatives has affected a very core outcome for women — safety and security.
It would be useful to identify a core outcome set, to standardize outcome definitions for efficacy and safety in clinical trials.
They indicate core outcome measurement sets for studies in hand OA, and list the methods and instruments that should be used to measure symptoms or structure.
Outcome measures were analysed based on five recommended core outcome domains; pain, work disability, back-specific function, generic health status and satisfaction with care.
To survey the outcomes used in Cochrane Reviews, as part of our work within the Core Outcome Measures in Effectiveness Trials Initiative.
Work aiming at standardizing core outcome measures and instruments for randomized clinical trials is ongoing.
A systematic review is the first step to establish a core outcome set and our outcome classification could help researchers to clarify the place of patient-important outcomes in core outcome sets for future RCTs in critically ill patients.
